Learn more
Log in
0 followers
TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.
Industries
Headquarters
Employees
Links
Stefanie Flückiger-Mangual
Roche
186 followers
AbbVie
129 followers
ADC Therapeutics
1 follower
Grifols
16 followers
Incyte
10 followers
Discover companies